Literature DB >> 1474541

Lack of enterohepatic circulation of the active metabolite of nabumetone in humans.

M A Brett1, G Buscher, E Ellrich, W H Greb, H J Kurth, G Rülander, B Schmerenbeck, R Haddock, A Thawley.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1474541

Source DB:  PubMed          Journal:  J Rheumatol Suppl        ISSN： 0380-0903


× No keyword cloud information.
  2 in total

Review 1.  Nabumetone: therapeutic use and safety profile in the management of osteoarthritis and rheumatoid arthritis.

Authors:  Thomas Hedner; Ola Samulesson; Peter Währborg; Hans Wadenvik; Kjell-Arne Ung; Anders Ekbom
Journal:  Drugs       Date:  2004       Impact factor: 9.546

Review 2.  Safety of the nonselective NSAID nabumetone : focus on gastrointestinal tolerability.

Authors:  Bernard Bannwarth
Journal:  Drug Saf       Date:  2008       Impact factor: 5.228
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.